Alkermes (ALKS)
44.11
0.00 (0.00%)
Upcoming Events
Latest Headlines
Alkermes to Report Third Quarter Financial Results on November 3, 2026
October 20, 2026 4:00 PM - BizWire
Truist Securities Starts Alkermes (ALKS) at Buy
October 16, 2026 5:18 AM - StreetInsider
Alkermes to present sleep disorder data at Sleep Europe 2026
October 13, 2026 7:00 AM - StreetInsider
Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at Sleep Europe 2026, Underscoring Leadership in Sleep Medicine Research
October 13, 2026 7:00 AM - BizWire
Form 4 Alkermes plc. For: Oct 08 Filed by: Reed Joshua
October 9, 2026 6:18 PM - SEC Filing
Form 4 Alkermes plc. For: Oct 07 Filed by: Whitaker Anne Clem
October 9, 2026 6:17 PM - SEC Filing
Stifel Reiterates Buy Rating on Alkermes (ALKS)
October 5, 2026 5:04 AM - StreetInsider
Form 4 Alkermes plc. For: Oct 02 Filed by: Gaffin David Joseph
October 2, 2026 6:22 PM - SEC Filing
Form 144 Alkermes plc. Filed by: Gaffin David Joseph
October 2, 2026 4:04 PM - SEC Filing
Goldman Sachs Resumes Alkermes (ALKS) at Neutral
September 24, 2026 4:59 AM - StreetInsider
Alkermes (ALKS) PT Raised to $61 at Baird
September 22, 2026 7:23 AM - StreetInsider
TD Cowen on Alkermes (ALKS): 'we view the update as important initial validation beyond sleep disorders'
September 21, 2026 10:04 AM - StreetInsider
Stifel on Alkermes (ALKS): 'big picture we still think orexins have real potential in ADHD'
September 21, 2026 8:16 AM - StreetInsider
Form 8-K Alkermes plc. For: Sep 21
September 21, 2026 7:11 AM - SEC Filing
Alkermes reports positive phase 1b results for ADHD drug ALKS 7290
September 21, 2026 7:00 AM - StreetInsider
Alkermes Announces Positive Phase 1b Results Demonstrating Clinical Proof-of-Concept for ALKS 7290 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
September 21, 2026 7:00 AM - BizWire
Form 3 Alkermes plc. For: Sep 14 Filed by: Whitaker Anne Clem
September 18, 2026 4:48 PM - SEC Filing
Form 8-K Alkermes plc. For: Sep 14
September 16, 2026 9:12 AM - SEC Filing
Alkermes adds Anne Whitaker to its board of directors
September 16, 2026 7:00 AM - StreetInsider
Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors
September 16, 2026 7:00 AM - BizWire
Alkermes Announces Launch of 9th Annual Alkermes Pathways Research Awards® Program
September 10, 2026 7:00 AM - BizWire
Mizuho Reiterates Outperform Rating on Alkermes (ALKS)
September 1, 2026 3:55 AM - StreetInsider
Alkermes narcolepsy drug data published in The Lancet Neurology
August 24, 2026 6:30 PM - StreetInsider
The Lancet Neurology Publishes Data From Alkermes’ Positive Vibrance-1 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 1
August 24, 2026 6:30 PM - BizWire
Form 4 Alkermes plc. For: Aug 17 Filed by: Nichols Christian Todd
August 17, 2026 6:54 PM - SEC Filing
Form 144 Alkermes plc. Filed by: Nichols Christian Todd
August 17, 2026 4:50 PM - SEC Filing
Form 4 Alkermes plc. For: Aug 03 Filed by: snyderman nancy lynn MD
August 12, 2026 11:03 AM - SEC Filing
Form 4 Alkermes plc. For: Aug 03 Filed by: Hopkinson Craig C.
August 12, 2026 11:03 AM - SEC Filing
Form 4 Alkermes plc. For: Aug 03 Filed by: Gaffin David Joseph
August 12, 2026 11:03 AM - SEC Filing
Form 8-K Alkermes plc. For: Aug 12
August 12, 2026 9:27 AM - SEC Filing
Form 4 Alkermes plc. For: Aug 05 Filed by: Jackson Blair Curtis
August 7, 2026 9:17 PM - SEC Filing
Form 4 Alkermes plc. For: Aug 03 Filed by: snyderman nancy lynn MD
August 3, 2026 7:17 PM - SEC Filing
Form 4 Alkermes plc. For: Aug 03 Filed by: Hopkinson Craig C.
August 3, 2026 7:13 PM - SEC Filing
Form 4 Alkermes plc. For: Aug 03 Filed by: Gaffin David Joseph
August 3, 2026 7:09 PM - SEC Filing
Form 144 Alkermes plc. Filed by: snyderman nancy lynn MD
August 3, 2026 4:34 PM - SEC Filing
Form 144 Alkermes plc. Filed by: Gaffin David Joseph
August 3, 2026 4:32 PM - SEC Filing
Form 144 Alkermes plc. Filed by: Hopkinson Craig C.
August 3, 2026 4:32 PM - SEC Filing
Form 8-K/A Alkermes plc. For: Feb 24
August 3, 2026 4:09 PM - SEC Filing
Weakness in this biotech stock is a buying opportunity: Mizuho
July 31, 2026 9:00 AM - StreetInsider
H.C. Wainwright Reiterates Neutral Rating on Alkermes (ALKS)
July 30, 2026 6:51 AM - StreetInsider
Alkermes (ALKS) PT Raised to $61 at JPMorgan
July 29, 2026 8:28 AM - StreetInsider
Alkermes (ALKS) PT Raised to $58 at Baird
July 29, 2026 6:38 AM - StreetInsider
Form S-8 Alkermes plc.
July 28, 2026 4:55 PM - SEC Filing
Form 10-Q Alkermes plc. For: Jun 30
July 28, 2026 9:23 AM - SEC Filing
Alkermes (ALKS) PT Raised to $65 at Piper Sandler
July 28, 2026 7:13 AM - StreetInsider
Alkermes (ALKS) Tops Q2 EPS by 2c; updates guidance
July 28, 2026 7:10 AM - StreetInsider
Form 8-K Alkermes plc. For: Jul 28
July 28, 2026 7:05 AM - SEC Filing
Alkermes plc Reports Second Quarter 2026 Financial Results
July 28, 2026 7:00 AM - BizWire
Full Article List
